Riskpilot← Back to searchSign inGet full accessMedort AB
ABActiveOrg 5591556856Nybrogatan 11 6 TrpGeneral medical practice activities · NACE 8621Est. 20181 employees
Revenue 2025
SEK 245K
+18% vs 2024
EBITDA margin
57.9%
-18% vs 2024
Equity ratio
86.6%
Financial strength
Net profit 2025
SEK 135K
-6% vs 2024
| Revenue | SEK 245K | +18% |
| EBITDA | SEK 142K | -18% |
| Net profit | SEK 135K | -6% |
| Total assets | SEK 610K | -8% |
| Equity | SEK 528K | -11% |
| Employees | 1 | — |
Legal name
Medort AB
Org number
5591556856
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
13 april 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
- Arbete som läkare inom ortopedi och allmän medicin. - Konsult uppdrag som läkare - Föreläsningar och utbildning inom ortopedi - Jobb med försäkringsärenden inom medicin, dvs invaliditetsintyg, arbetsskador, bedömning av invaliditets grad. -värdepapper investeringar. Aktier och fonder- - Konsult och utbildningsuppdrag inom vindsurfing, fotografi och musik (gitarr spel)
Address
Nybrogatan 11 6 Trp
Email
medortab@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 172 | 187 | 181 | 207 | 245 |
| Staff expenses | — | −5 | −0 | −8 | −47 |
| EBITDA | 145 | 145 | 163 | 173 | 142 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 145 | 145 | 163 | 173 | 142 |
| Net financials | — | −0 | 0 | 9 | 28 |
| Profit before tax | 144 | 144 | 163 | 182 | 170 |
| Tax | −31 | −30 | −34 | −38 | −35 |
| Net profit | 113 | 114 | 129 | 144 | 135 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 427 | 472 | 622 | 661 | 610 |
| Equity | 306 | 421 | 550 | 594 | 528 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 121 | 52 | 72 | 67 | 82 |
| Total debt | 121 | 52 | 72 | 67 | 82 |
EBITDA margin
57.9%
This company
15.8%
Market median
+266% vs market
20212025
Equity ratio
86.6%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
25.5%
This company
18.4%
Market median
+39% vs market
20212025
Net profit margin
55.0%
This company
8.1%
Market median
+579% vs market
20212025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medort AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Mikael Waldenström | Deputy Board Member | 0 companies |
| Philip Erland Waldenström | Board of Directors | 0 companies |